FDG-PET is not useful in early pancreatic cancer diagnosis

Better tools for early detection and accurate staging of pancreatic cancer are needed. The role of 18F-fluorodeoxyglucose (FDG)-PET in this setting is controversial. The results of a large retrospective study analyzing the value of FDG-PET in the diagnosis of pancreatic ductal adenocarcinoma are dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Strobel, Oliver (VerfasserIn) , Büchler, Markus W. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Nature reviews. Gastroenterology & hepatology
Year: 2013, Jahrgang: 10, Heft: 4, Pages: 203-205
ISSN:1759-5053
DOI:10.1038/nrgastro.2013.42
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nrgastro.2013.42
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nrgastro.2013.42
Volltext
Verfasserangaben:Oliver Strobel & Markus W. Büchler
Beschreibung
Zusammenfassung:Better tools for early detection and accurate staging of pancreatic cancer are needed. The role of 18F-fluorodeoxyglucose (FDG)-PET in this setting is controversial. The results of a large retrospective study analyzing the value of FDG-PET in the diagnosis of pancreatic ductal adenocarcinoma are discussed here.
Beschreibung:Gesehen am 16.03.2022
Beschreibung:Online Resource
ISSN:1759-5053
DOI:10.1038/nrgastro.2013.42